tiprankstipranks
Advertisement
Advertisement

MBX Stock Latest News

MBX: Leadership Transition, Pipeline Visibility Support Maintained Buy Rating and Unchanged $91 Price Target
RatingsMBX: Leadership Transition, Pipeline Visibility Support Maintained Buy Rating and Unchanged $91 Price Target
5d ago
MBX
Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement
PremiumThe Fly
Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement
8d ago
FBK
LEU
MBX Biosciences Announces CEO Transition and Leadership Updates
PremiumCompany Announcements
MBX Biosciences Announces CEO Transition and Leadership Updates
8d ago
8K
MBX
MBX Biosciences CEO Kent Hawryluk steps down, Steve Hoerter succeeds
PremiumThe Fly
MBX Biosciences CEO Kent Hawryluk steps down, Steve Hoerter succeeds
8d ago
MBX
MBX Biosciences Completes STEADI Trial, Putting Imapextide on Investors’ Radar
PremiumCompany Announcements
MBX Biosciences Completes STEADI Trial, Putting Imapextide on Investors’ Radar
19d ago
MBX
Analyst Reiterates Buy on MBX, Maintains $91 Price Target on Canvuparade’s Once-Weekly Hypoparathyroidism Opportunity
PremiumRatingsAnalyst Reiterates Buy on MBX, Maintains $91 Price Target on Canvuparade’s Once-Weekly Hypoparathyroidism Opportunity
1M ago
MBX
MBX Biosciences down 19% at $30.05 after announcing canvuparatide study results
Premium
The Fly
MBX Biosciences down 19% at $30.05 after announcing canvuparatide study results
1M ago
MBX
MBX Biosciences unveils positive Phase 2 canvuparatide results
Premium
Company Announcements
MBX Biosciences unveils positive Phase 2 canvuparatide results
1M ago
8K
MBX
MBX Biosciences announces results from Avail, canvuparatide trials
PremiumThe Fly
MBX Biosciences announces results from Avail, canvuparatide trials
1M ago
MBX
MBX Biosciences Shareholders Approve Directors and Auditor
PremiumCompany Announcements
MBX Biosciences Shareholders Approve Directors and Auditor
2M ago
8K
MBX
MBX Biosciences price target raised to $56 from $50 at Stifel
PremiumThe Fly
MBX Biosciences price target raised to $56 from $50 at Stifel
2M ago
MBX
MBX Biosciences price target raised to $70 from $66 at Barclays
PremiumThe Fly
MBX Biosciences price target raised to $70 from $66 at Barclays
2M ago
MBX
MBX Biosciences price target raised to $86 from $76 at Citizens
PremiumThe FlyMBX Biosciences price target raised to $86 from $76 at Citizens
2M ago
MBX
MBX Biosciences price target raised to $70 from $50 at Truist
Premium
The Fly
MBX Biosciences price target raised to $70 from $50 at Truist
2M ago
MBX
MBX Biosciences Phase 1 data supports once-monthly dosing for MBX 4291
Premium
The Fly
MBX Biosciences Phase 1 data supports once-monthly dosing for MBX 4291
2M ago
MBX
MBX Biosciences Highlights Positive Phase 1 Obesity Data
PremiumCompany Announcements
MBX Biosciences Highlights Positive Phase 1 Obesity Data
2M ago
8K
MBX
Advancing Pipeline and Key Data Catalysts Drive Analyst’s Bullish View on MBX
PremiumRatings
Advancing Pipeline and Key Data Catalysts Drive Analyst’s Bullish View on MBX
3M ago
MBX
MBX Biosciences reports Q1 EPS (51c), consensus (58c)
PremiumThe Fly
MBX Biosciences reports Q1 EPS (51c), consensus (58c)
3M ago
MBX
MBX Biosciences appoints Mark Soued as chief commercial officer.
PremiumThe Fly
MBX Biosciences appoints Mark Soued as chief commercial officer.
3M ago
MBX
ALNY
MBX Biosciences initiated with an Outperform at LifeSci Capital
PremiumThe FlyMBX Biosciences initiated with an Outperform at LifeSci Capital
4M ago
MBX
Options Volatility and Implied Earnings Moves Today, March 23, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
4M ago
LAR
MBX
MBX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MBX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
MBX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >